Research

Genetic Frontiers Million Person Study
First Opinion

Community engagement is key to clinical trial recruitment and diversity

By Bobby Clark and Ronnie Tepp

Nantucket lyme landscape
First Opinion

Gene editing to stop Lyme disease: caution is warranted

By Allison Snow

Kevin Esvelt of MIT
First Opinion

A community-guided genome editing project can fight Lyme disease

By Kevin M. Esvelt

Health

Can a new Lyme disease vaccine overcome a history of distrust and failure?

By Brittany Flaherty

Mouse cell micro
In the Lab

Scientists routinely cure brain disorders in mice but not us. A new study helps explain why

By Sharon Begley

"All of Us" participant
Health

NIH will soon share genetic data with those who participated in precision medicine study

By Lev Facher

Patient with IV
Health

Many clinical trials for new cancer drugs didn’t include any data on race

By Megan Thielking

CBD cocktail
First Opinion

Cannabidiol confusion: lofty promises and barriers to research

By Beatriz H. Carlini, Gregory Carter, and Nephi Stella

Alzheimer's Iowa state fair
Politics

Alzheimer’s advocates are swarming the Iowa State Fair, pushing politicians to consider policies to fight the disease 

By Nicholas Florko

Health Tech

With Alzheimer’s research at a crossroads, AI might point the way forward

By Casey Ross

Seeding Labs
In the Lab

New life of lab equipment makes science possible for researchers returning to their home countries

By Diana Cai

DNA crowd
Health Tech

Health tech companies are swallowing up consumers’ DNA. Can Congress safeguard what they do with it?

By Andrew Joseph

Pharmalot

Pharmalittle: Pay-to-play clinical trials draw scrutiny; Chinese drug ingredients called U.S. threat

By Elizabeth Cooney

Vending Machine
In the Lab

Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny

By Rebecca Robbins

electric fan
Health

Contrary to some public health advice, fans may be safe to use during heat waves

By Lauren Joseph and Ruth Hailu

Vitamin aisle
First Opinion

Why the term ‘natural’ is so seductive — and possibly misleading

By Brian Meier, Amanda Dillard, and Courtney Lappas

Wild mouse
In the Lab

Using a more diverse microbiome, scientists look to create a better lab mouse

By Shraddha Chakradhar

Digital kidney
Health Tech

DeepMind AI predicts acute loss of kidney function two days in advance, study shows

By Casey Ross

Brain and placenta organoids
In the Lab

With mini-placentas and mini-brains, scientists try to unravel the roots of psychiatric disorders

By Sharon Begley

Marijuana plants drying
Politics

Déjà vu all over again: Another year passes without approval of new suppliers of marijuana for research

By Andrew Joseph

Alzheimer neuron network with amyloid plaques
Health

A Q&A with NIA’s director on Alzheimer’s: What’s gone wrong, and what’s going right?

By Meghana Keshavan

Biotech

A richly funded CRISPR alternative has a reproducibility problem

By Damian Garde

Money cut up
First Opinion

‘Meticulous’ study shows that value-based care works

By Andrew Dreyfus

Health

Fitbits and other wearables may not accurately track heart rates in people of color

By Ruth Hailu

Merck logo
Health

Merck unveils early data on HIV drug it says could be ‘a game changer’

By Matthew Herper

Candida auris fungi
Health

The superbug Candida auris is giving rise to warnings — and big questions

By Helen Branswell

Glioblastoma Cells
In the Lab

A new kind of CAR-T becomes a micro-pharmacy, eliminating glioblastoma in mice

By Sharon Begley

Doctor and patient
First Opinion

Do as the doctor says, not as he or she does

By Michael D. Frakes, Jonathan Gruber, and Anupam B. Jena

Hippocampus & Alzheimer's
In the Lab

Role of seizures in Alzheimer’s disease is gaining overdue attention

By Lauren Aguirre

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy